Novel Anti-CRR9/CLPTM1L Antibodies with Antitumorigenic Activity Inhibit Cell Surface Accumulation, PI3K Interaction, and Survival Signaling
László G. Puskás(University of Szeged), Michael A. James(Harvard University), Imola Mán(University of Szeged), Gábor J. Szebeni(University of Szeged), Susan Tsai(The Ohio State University Wexner Medical Center), László Tiszlavicz(University of Szeged)
Cited by 21
Related Papers
Development of primary human pancreatic cancer organoids, matched stromal and immune cells and 3D tumor microenvironment models
|BMC Cancer|2018|391
Plasma extracellular RNA profiles in healthy and cancer patients
|Scientific Reports|2016|294
Circulating giant macrophages as a potential biomarker of solid tumors
|Proceedings of the National Academy of Sciences|2014|281
Microwave Ablation for Hepatic Malignancies
|Annals of Surgery|2013|254